Thérapie génique chez les 5 à 11 ans : quels sont les risque

par glevesque , samedi 27 novembre 2021, 03:23 (il y a 1618 jours)

Thérapie génique chez les 5 à 11 ans : quels sont les risques ? Nicolas Derome
Réinfo Covid Québec: https://reinfocovid.ca/
Télécharger la vidéo : https://archive.org/details/therapie-genique-chez-les-5-a-11-ans

RÉFÉRENCES DE CETTE PRÉSENTATION :
(1) Ledford, Heidi. “Deaths from COVID 'incredibly rare' among children.” Nature vol. 595,7869 (2021): 639.

(2) Wu & McGoogan. 2020. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020 February 24

(3) CDC COVID-19 Response Team. Coronavirus disease 2019 in children—United States, February 12–April 2, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(14):422-426.

(4) Gudbjartsson DF, et al. Spread of SARS-CoV-2 in the Icelandic population. N Engl J Med 2020:NEJMoa2006100.

(5) Lavezzo E, et al. Suppression of COVID-19 outbreak in the municipality of Vo, Italy. medRxiv 2020 [preprint]. doi:10.1101/2020.04.17.20 053157.

(6) Lu X, et al. SARS-CoV-2 infection in children. N Engl J Med 2020:NEJMc2005073. doi:10.1056/NEJMc2005073.

(7) Jing et al. Household secondary attack rate of COVID-19 and associated determinants. medRxiv 2020 [preprint]. doi:10.1101/2020.04.11.20056010.

(8) National Centre for Immunisation and SurveillanceCOVID-19 in schools – the experience in NSW, 2020. http:// ncirs.org.au

(9) The National Institute for Public Health and the Environment (RVIM).Children and COVID-19, 2020. https://www. rivm. nl/ en/ novel- coronaviruscovid-19/ children- and- covid- 19

10) Weisberg, Stuart P et al. “Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum.” Nature immunology vol. 22,1 (2021): 25-31.

(11) Pierce, C. A. et al. Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients. Sci. Transl. Med. 12, eabd5487 (2020).

(12) Gruber, C. N. et al. Mapping systemic inflammation and antibody responses in multisystem inflammatory syndrome in children (MIS-C). Cell https://doi.org/10.1016/j.cell.2020.0... (2020).
https://www.cell.com/cell/fulltext/S0092-8674(20)31231-9?_returnURL=https%3A%2F%2Flinki...

(13) Singanayagam et al. 2021. “Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study.” The Lancet. Infectious diseases, S1473-3099(21)00648-4.

---
Croire c'est bien, mais savoir sait encore mieux !